At the ISPOR Annual Meeting, Journal of Clinical Pathways sat down with the Innovation and Value Initiative team to delve into their latest efforts and involvement in the meeting, including leading discussions and debates on quality-adjusted life-years, value definition and measurement, and a 4-state treatment sequence model for non-small cell lung cancer.